The title compound (alternative name: 2-O-terf-butylsilyl-3,4-0-isopropylidene-1,5,6-trideoxy-N-hydroxy-1,5-imino-D-mannitol) was prepared as follows. Reduction of an (E/Z) mixture of 2-0-fe/7-butyldimethylsilyl-3,4-0-isopropylidene-L-arabino-5-hexenose oxime [1] with sodium cyanoborohydride in methanol at pH = 3 afforded the corresponding primary hydroxylamine which underwent Cope-House cyclization [2-5] in chloroform at room temperature to give the title compound [6, 7] . This was obtained as a single diastereomer and was purified by column chromatography on silica gel (ethyl acetate / petrol ether 15:85). Crystallization from methanol afforded colourless plates (mp 438-439 Κ, [<z]° = +23 (c = 1.0, CHCI3).
Discussion
The hydroxylamine function builds up a system of dimers joint by hydrogen bond pairing. The O-H group works as donor. The Η-Ν distance to the N-acceptor is 2.15 A and the O-H-Ν angle is 154°. The figure shows the distinct envelope conformation of the dioxolan moiety. As expected, the piperidine system has a chair conformation. In the molecule packing, we observe polar layers due to the hydrogen bond systems of the hydroxylamine moieties, and non-polar layers made by the alkyl-silyl moieties stacked along the c axis. The piperidine ring systems show a face-to-face orientation along the a axis. (2) 0(2) 
